These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6959 related articles for article (PubMed ID: 2529220)

  • 1. Presence on a human melanoma of multiple antigens recognized by autologous CTL.
    Van den Eynde B; Hainaut P; Hérin M; Knuth A; Lemoine C; Weynants P; van der Bruggen P; Fauchet R; Boon T
    Int J Cancer; 1989 Oct; 44(4):634-40. PubMed ID: 2529220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic heterogeneity of a human melanoma tumor detected by autologous CTL clones.
    Degiovanni G; Lahaye T; Hérin M; Hainaut P; Boon T
    Eur J Immunol; 1988 May; 18(5):671-6. PubMed ID: 2967757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of antigens recognized on human melanoma cells by A2-restricted cytolytic T lymphocytes (CTL).
    Wölfel T; Hauer M; Klehmann E; Brichard V; Ackermann B; Knuth A; Boon T; Meyer Zum Büschenfelde KH
    Int J Cancer; 1993 Sep; 55(2):237-44. PubMed ID: 7690346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of stable cytolytic T-cell clones directed against autologous human melanoma.
    Hérin M; Lemoine C; Weynants P; Vessière F; Van Pel A; Knuth A; Devos R; Boon T
    Int J Cancer; 1987 Mar; 39(3):390-6. PubMed ID: 3493226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.
    Wölfel T; Klehmann E; Müller C; Schütt KH; Meyer zum Büschenfelde KH; Knuth A
    J Exp Med; 1989 Sep; 170(3):797-810. PubMed ID: 2788708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigens recognized on a melanoma cell line by autologous cytolytic T lymphocytes are also expressed on freshly collected tumor cells.
    Degiovanni G; Hainaut P; Lahaye T; Weynants P; Boon T
    Eur J Immunol; 1990 Aug; 20(8):1865-8. PubMed ID: 2209693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene.
    Chiari R; Foury F; De Plaen E; Baurain JF; Thonnard J; Coulie PG
    Cancer Res; 1999 Nov; 59(22):5785-92. PubMed ID: 10582700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
    Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
    J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones.
    Bernhard H; Karbach J; Wölfel T; Busch P; Störkel S; Stöckle M; Wölfel C; Seliger B; Huber C; Meyer zum Büschenfelde KH
    Int J Cancer; 1994 Dec; 59(6):837-42. PubMed ID: 7989126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.
    Anichini A; Maccalli C; Mortarini R; Salvi S; Mazzocchi A; Squarcina P; Herlyn M; Parmiani G
    J Exp Med; 1993 Apr; 177(4):989-98. PubMed ID: 8459226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection.
    Knuth A; Wölfel T; Klehmann E; Boon T; Meyer zum Büschenfelde KH
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2804-8. PubMed ID: 2784858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection.
    Lehmann F; Marchand M; Hainaut P; Pouillart P; Sastre X; Ikeda H; Boon T; Coulie PG
    Eur J Immunol; 1995 Feb; 25(2):340-7. PubMed ID: 7875194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.
    Mukherji B; Guha A; Chakraborty NG; Sivanandham M; Nashed AL; Sporn JR; Ergin MT
    J Exp Med; 1989 Jun; 169(6):1961-76. PubMed ID: 2471770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal analysis of cytotoxic T lymphocytes (CTL) against autologous melanoma. Classification based on phenotype, specificity and inhibition by monoclonal antibodies to T cell structures.
    Hersey P; MacDonald M; Schibeci S; Burns C
    Cancer Immunol Immunother; 1986; 22(1):15-23. PubMed ID: 2423240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients.
    Kan-Mitchell J; Liggett PE; Harel W; Steinman L; Nitta T; Oksenberg JR; Posner MR; Mitchell MS
    Cancer Immunol Immunother; 1991; 33(5):333-40. PubMed ID: 1831067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
    Brichard V; Van Pel A; Wölfel T; Wölfel C; De Plaen E; Lethé B; Coulie P; Boon T
    J Exp Med; 1993 Aug; 178(2):489-95. PubMed ID: 8340755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of shared melanoma antigen by HLA-A2-restricted cytolytic T cell clones derived from human tumor-infiltrating lymphocytes.
    Viret C; Davodeau F; Guilloux Y; Bignon JD; Semana G; Breathnach R; Jotereau F
    Eur J Immunol; 1993 Jan; 23(1):141-6. PubMed ID: 8419164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of naturally processed peptides recognized by cytolytic T lymphocytes (CTL) on human melanoma cells in association with HLA-A2.1.
    Wölfel T; Schneider J; Meyer Zum Büschenfelde KH; Rammensee HG; Rötzschke O; Falk K
    Int J Cancer; 1994 May; 57(3):413-8. PubMed ID: 8169004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide derived from melanocytic protein gp100 and presented by HLA-B35 is recognized by autologous cytolytic T lymphocytes on melanoma cells.
    Vigneron N; Ooms A; Morel S; Ma W; Degiovanni G; Van den Eynde BJ
    Tissue Antigens; 2005 Feb; 65(2):156-62. PubMed ID: 15713214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 348.